Table 5.
Changes in cellular immune inflammation markers.
| Competitive periods / cellular immune markers | T1 | T2 | T3 | p-value | ES (Cohen’s d) ES1 − 3–ES2 − 3 |
|---|---|---|---|---|---|
| Leucocytes (/mm3) | 6220.70 ± 1350.76 | 6113.33 ± 1419.69 | 6690.00 ± 1707.88 | 0.007*,# | -0.49 ; -0.56 |
| Neutrophils (/mm3) | 3038.47 ± 789.4 | 2838.21 ± 906.80 | 4115.16 ± 1055.11 | 0.04*,# | -0.64 ; -0.43 |
| Lymphocytes (/mm3) | 2763.05 ± 710.17 | 2752.37 ± 650.98 | 2215.72 ± 655.04 | 0.038*,# | -0.25 ; -0.48 |
| Monocytes (/mm3) | 228.71 ± 58.95 | 292.07 ± 90.72 | 313.13 ± 120.22 | 0.003#† | -0.77 ; 0.04 |
| Eosinophils (/mm3) | 149.20 ± 125.55 | 200.42 ± 121.50 | 254.88 ± 155.55 | 0.002*† | -0.78 ; -0.40 |
| Basophils (/mm3) | 35.31 ± 8.02 | 38.30 ± 14.57 | 44.16 ± 9.31 | 0.074 | -0.80 ; -0.53 |
| Platelets (× 103/mm3) | 237.80 ± 42.31 | 243.40 ± 43.52 | 230.60 ± 46.01 | 0.32 | 0.16 ; 0.29 |
| NLR (A.U.) | 1.16 ± 0.35 | 1.04 ± 0.30 | 1.92 ± 0.48 | ˂ 0.001*,# | -0.99 ; -1.01 |
| PLR (A.U.) | 90.70 ± 21.52 | 91.52 ± 20.35 | 109.35 ± 32.42 | 0.015*,# | -0.21 ; -0.44 |
| SII (× 103/mm3) | 270.68 ± 75.62 | 250.95 ± 66.40 | 434.77 ± 106.59 | ˂ 0.001*,# | -0.75 ; -0.71 |
AU, arbitrary units; ES, effect size; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; SII, systemic immune inflammation index.
* significant differences between T2 and T3, p < 0.05.
# significant difference between T3 and T1, p < 0.05.
† significant differences between T1 and T2, p < 0.05.